For extended anticoagulation after venous thromboembolism (VTE) in patients with active cancer, a lower dose of apixaban ...

All these recommendations are based on weak evidence obtained from small, single-center and retrospectively analyzed cohorts; the present practice in this field is highly variable and appears to ...